Affect Therapeutics
PrivateLast Round
Series B
Nov 5, 2025
Total Funding Raised
$75.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Affect Therapeutics is a digital health company that provides a smartphone-based virtual clinic for substance use and mental health disorders, utilizing contingency management, counseling, and medication-assisted treatment.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Affect Therapeutics Comparables
Compare Affect Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WEconnect Health Management | 82% | |
| Workit Health | 81% | |
| Monument | 80% | |
Affect Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 5, 2025 | ||||
| Series B | Sep 23, 2025 | ||||
| Series A | Jul 12, 2023 | ||||
| Grant | Sep 30, 2021 | ||||
| Seed | Aug 31, 2021 | ||||
Seed | Apr 21, 2021 |
Key People
Founding team and executive leadership
Affect Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlleyCorp | Seed, Series A |
| ARTIS Ventures | Series B, Series A |
| Allumia Ventures | Series B |
| Samsung Next TLV | Series A |
| LifeArc Ventures | Series B, Series A |
| Kapor Capital | Seed |
| Acumen | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
Monthly visitors increased 141% MoM.
- Sep 23, 2025
$26M round led by Allumia Ventures.
Affect Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Affect Therapeutics's valuation, stock price, and market status.